Disease-free probability after the first primary ductal carcinoma in situ of the breast: a comparison between African-American and White-American women
Tóm tắt
Compelling evidence about the differences in the biology and behavior of invasive breast cancer between African-American (AA) and White-American (WA) women motivate inquiry into comparing the clinicopathology of non-invasive breast cancer (ductal carcinoma in situ, DCIS). AA and WA women diagnosed with their first primary DCIS between 1990 and 1999 were identified from the institutional tumor registry. Data on method of presentation, treatment, and patient characteristics were retrieved from electronic medical records. Patients were followed up through the medical records until the diagnosis of a subsequent cancer or the last day of contact with the institution. A total of 100 (29.6%) AAs and 236 (70.4%) WAs with the mean age of 60 (SD ± 13) and 57 (SD ± 12), respectively, contributed to this study. DCIS was detected during routine screening mammography for 81% (n = 81) of AAs and 88.4% (n = 206) of WAs (P = 0.073). Differences in the distributions of grade, margin status, necrosis, or treatment modalities were not statistically significant between AAs and WAs. Analysis of competing risks Cox proportional hazard multivariate modeling yielded a significant 8-year cumulative risk of a second cancer for AAs but only in the ipsilateral breast (HR = 3.96, 95% CI 1.42–11.04, P = 0.01). Despite comparable clinical presentation and treatment, 8 years after the initial treatment, AAs experienced a higher risk of second breast cancer in ipsilateral but not in the contralateral breast. The observed excess risk of a second cancer in the ipsilateral breast may suggest of intrinsic differences in the biology of cancer.
Tài liệu tham khảo
Carey LA, Perou CM, Livasy CA, Dressler LG, Gowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston SL, Deming SL, Geradits J, Cheang MCU, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 295:2492–2502
Newman LA, Martin LK (2007) Disparities in breast cancer. Curr Probl Cancer 31:134–156
Newman LA, Bunner S, Carolin K, Bouwman D, Kosir MA, White M, Schwartz A (2002) Ethnicity related differences in the survival of young breast cancer patients. Cancer 95:21–27
Surveillance Epidemiology and End Results (SEER) SEER.cancer.gov/csr/1975_2007/browse_csr.php?section=4&page=sect_04_table.11html. Accessed on 5 April 2010
Demicheli R, Retksy MW, Hrushesky WJM, Baum M, Gukas ID, Jatoi I (2007) Racial disparities in breast cancer outcome: insights into host-tumor interactions. Cancer 110:1880–1888
Healthy People 2010 (2000) Understanding and improving health. US Department of Health and Human Services, Washington, DC
Nassar H, Sharafaldeen B, Visvanathan K, Visscher D (2009) Ductal carcinoma in situ in African-American versus Caucasian-American women. Cancer 115:3181–3188
Kerlikowske K, Molinaro A, Cha I, Ljung BM, Ernester VL, Stewart K, Chew K, Moore DH, Waldman F (2003) Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst 95:1692–1702
Warren JL, Weaver DL, Bocklage T, Key CR, Platz CE, Cronin KA, Ballard-Barbash R, Willey SC, Harlan LC (2005) The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis. Cancer 104:1840–1848
Joslyn SA (2006) Ductal carcinoma in situ; Trends in geographic, temporal, and demographic patterns of care and survival. Breast J 12:20–27
Li C, Malone KE, Saltzman BS, Daling JR (2006) Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988–2001. Cancer 106:2104–2112
Cox DR (1972) Regression models and life-tables. J R Stat Soc (Ser B Methodol) 34:187–220
Hosmer D, Lemeshow S (1997) Applied logistic regression. Wiley, New York
Heckman JJ, Honoré BOE (1989) The identifying of the competing risks models. Biometrika 76:325–330
Komenka IK, Martinez ME, Pennington RE Jr, Hsu CH, Clare SE, Thompson PA, Murphy C, Zork NM, Goulet RJ Jr (2010) Race and ethnicity and breast cancer outcome in an underinsured population. J Natl Cancer Inst 102:1178–1187
Dunn BK, Agurs-Collins T, Browne D, Lubet R, Johnson KA (2010) Health disparities in breast cancer: biology meets socioeconomic status. Breast Cancer Res Treat 121:281–292
Innos K, Horn-Ross PL (2003) Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in Californian women. Cancer 97:1099–1106
Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y, McCue P, Schwaetz GF, Park PK, Rosenberg AL, Brill K, Mitchell EP (2007) Differences in breast carcinoma characteristics in newly diagnosed African-America and Caucasian patients: a single-institution compilation compared with the National Cancer Institute’s Surveillance, Epidemiology, and End Results database. Cancer 110:876–884
Brawley OW (2002) Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst 94:471–473
Freeman HP (2004) Poverty, culture and social injustice: determinants of cancer disparities. CA Cancer J Clin 54:72–77
Brawley OW (2009) Is race really a negative prognostic factor for cancer? J Natl Cancer Inst 101:970–971
Smith GL, Shih YCT, Xu Y, Giordano SH, Smith BD, Perkins GH, Tereffe W, Woodward WA, Buchholz TA (2010) Racial disparities in the use of radiotherapy after breast-conserving surgery: a national Medicare Study. Cancer 116:734–741
Reisch LM, Barton MB, Fletcher SW, Kreuter W, Elmore JG (2000) Breast cancer screening use by African-Americans and Whites in an HMO. J Gen Intern Med 15:229–234
Jatoi I, Anderson WF, Rao SR, Devesa SS (2005) Breast cancer trends among Black and White women in the United States. J Clin Oncol 23:7836–7841
Livasy CA, Perou CM, Karaca G, Cowan DW, Maia D, Jackson S, Tse CK, Nyante S, Millikan RC (2007) Identification of a basal-like subtype of breast ductal carcinoma in situ. Hum Pathol 38:197–204
Rudloff U, Brogi E, Reiner AS, Goldberg JI, Brockway JP, Wynveen CA, McCormick B, Patill S, Van Zee KJ (2010) The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy. Ann Surg 251:583–591
Dick AW, Sorbero MS, Ahrent GM, Hayman JA, Gold HT, Schiffhauer L, Stark A, Griggs JJ (2011) Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons. J Natl Cancer Inst 103:92–104
Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S (2005) Current perceptions regarding surgical margins status after breast conserving therapy: results of a survey. Ann Surg 241:629–639
Dunne C, Burke JP, Morrow M, Kell MR (2009) Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 27:1615–1620
Krieger N, Chen JT, Waterman PD (2011) Temporal trends in the black/white breast cancer case ration for estrogen receptor status: disparities are historically contingent, not innate. Cancer Causes Control 22:511–524
Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Børresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implication. PNAS 98:10869–10874
Millkan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109:123–139